ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      98,351.81
      0.15%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atossa Therapeutics Inc (ATOS)

      7. Atossa Therapeutics Inc (ATOS) News

      Atossa Therapeutics Inc

      Atossa Therapeutics Inc (ATOS)

      NASDAQ
      1.01
      0.0499
      (5.20%)
      Closed January 05 4:00PM
      Delayed by 15 minutes
      1.0299
      0.0199
      (1.97%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      ATOS News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 10 2024
      ATOS (5.20%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 19 2024
      ATOS (5.20%)

      Form 424B5 - Prospectus [Rule 424(b)(5)]
      Edgar (US Regulatory)
      November 19 2024
      ATOS (5.20%)

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors
      Edgar (US Regulatory)
      November 08 2024
      ATOS (5.20%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 04 2024
      ATOS (5.20%)

      ATOS Discussion

      View Posts
      XenaLives XenaLives 4 months ago
      Why on earth did it take me so long to find this?



      Following...

      https://x.com/stevenquay
      👍️0
      XenaLives XenaLives 4 months ago
      I think I'm in love... LOL!!!



      Historical perspective:

      👍️0
      XenaLives XenaLives 4 months ago
      More interesting...

      https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      XenaLives XenaLives 4 months ago
      ATOS chart...

      👍️0
      XenaLives XenaLives 4 months ago
      Interesting .. also from Google...

      A response to this query...

      what is unique about atossa therapeutics inc

      Response...

      Is Atossa Therapeutics a good buy?
      Why is Atossa stock dropping?
      Who owns Atossa Therapeutics?
      What is the target price for Atossa Genetics?
      Stock Price Target ATOS
      High $6.25
      Median $6.00
      Low $4.00
      Average $5.42
      Current Price $1.39

      ATOS | Atossa Therapeutics Inc. Analyst Estimates & Rating - WSJ

      WSJ
      https://www.wsj.com › quotes › ATOS › research-ratings
      Search for: What is the target price for Atossa Genetics?
      What is the stock price forecast for Atossa Therapeutics in 2025?
      What does Atossa Therapeutics do?


      👍️0
      XenaLives XenaLives 4 months ago
      From Google Generative AI:


      Atossa Therapeutics is a clinical-stage biopharmaceutical company that develops innovative medicines for oncology, with a focus on breast cancer and other breast conditions. Some unique aspects of Atossa Therapeutics include:
      Patented (Z)-endoxifen
      Atossa has patented the chemical process and composition of matter for (Z)-endoxifen, as well as a patented oral enteric capsule formulation.
      Phase 2 I-SPY 2 Clinical Trial
      Atossa is fully enrolling this trial, which is evaluating (Z)-endoxifen as a neoadjuvant treatment for patients with newly diagnosed estrogen receptor-positive breast cancer.
      Phase 2 trials
      Atossa is currently studying (Z)-endoxifen in four Phase 2 trials, including one in healthy women with measurable breast density, one in women diagnosed with ductal carcinoma in situ, and two other studies.
      U.S. patents
      Atossa's (Z)-endoxifen is protected by three issued U.S. patents and numerous pending patent applications.
      👍️0
      XenaLives XenaLives 4 months ago
      Intriguing science...
      👍️0
      XenaLives XenaLives 4 months ago

      (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

      https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-00701&r=1
      👍️0
      XenaLives XenaLives 4 months ago
      Link to Atossa pipeline...
      https://atossatherapeutics.com/product-pipeline/
      👍️0
      XenaLives XenaLives 4 months ago
      Following - some valid science is going on here...
      👍️0
      glenn1919 glenn1919 5 months ago
      ATOS....................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 6 months ago
      ATOS.........................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 6 months ago
      ATOS...............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 8 months ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️ 1
      Joeyohso Joeyohso 9 months ago
      Also no debt and 90m+ in cash. That is unheard of for a research pharma company. They also are extending the employee stock purchase program for all of 2024. This stock is a gem
      👍️0
      ShadowDiviner72 ShadowDiviner72 9 months ago
      New PR, and data release shows that Endoxifen does not only stop the tumor from growing...

      It even shows that it eliminates the tumor !!!!!! They cured a patient from breast cancer by taking a simple pill during 6 months!

      INCREDIBLE
      👍️0
      glenn1919 glenn1919 9 months ago
      ATOS...........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Joeyohso Joeyohso 9 months ago
      Why the dump today? I was able to grab some at 1.65
      👍️0
      Monksdream Monksdream 9 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 9 months ago
      ATOS new 52 hi
      👍️0
      Monksdream Monksdream 9 months ago
      ATOS 10Q due 4/5
      👍️0
      Monksdream Monksdream 9 months ago
      ATOS new 52 hi
      👍️0
      glenn1919 glenn1919 9 months ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      ATOS..LEVEL 2 LOOKING VERY NICE IN PRE
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      ATOS...GET READY TO RUMBLE...WE ARE LOCKED IN AND LOADED TO 1.73
      👍️0
      glenn1919 glenn1919 10 months ago
      ATOS.............................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 10 months ago
      ATOS.........................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 11 months ago
      ATOS..................................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 1 year ago
      ATOS................https://stockcharts.com/h-sc/ui?s=ATOS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Birdbrain Ideas Birdbrain Ideas 1 year ago
      There hasn't been a post on this board in six weeks. If these Stage 2 trials turn out well, this board will light up along with the share price.
      👍️0
      Laster Laster 2 years ago
      I loved that wall at $1.04 yesterday. It was calling my name. I was too slow.
      Then it was taken out. I wasn’t too upset because….
      I was lucky enough for another wall at $1.05 that I helped take out. Then boom.
      Chart looked good. News good. Repurchase plan news excellent.
      What’s not to like.
      Hope to see if move back above $2.
      Good luck.
      👍️0
      tw0122 tw0122 2 years ago
      Looking good. Hidden gem not any longer
      👍️0
      killrEngineer killrEngineer 2 years ago
      Wow. No comments?
      10 million share repurchase announcement yesterday and study enrollment announcement today.
      👍️0
      DrJinx DrJinx 2 years ago
      This aged like milk. How's that priming for a big run up working out for you? Maybe someday people will realize the company is smoke and mirrors. Keep in mind your CEO is old as F, he dies... this thing tanks even harder.
      👍️0
      Engle1488 Engle1488 2 years ago
      We are primed for a big run up people. In at 1.04
      👍️0
      Agreed Agreed 3 years ago
      The market cap is less than their holdings in cash...clearly undervalued.
      👍️0
      Agreed Agreed 3 years ago
      Insider buying by CEO and CFO, new patent protections...looking promising.
      👍️0
      DollarSquad DollarSquad 3 years ago
      Yes. You likely lost a lot of money. This investment is worthless. RMSL
      👍️0
      4MVault 4MVault 3 years ago
      Did something just happen?
      👍️0
      slugo1 slugo1 3 years ago
      Looking for bottom here
      👍️0
      ttottip ttottip 3 years ago
      Yes, very soon. This will reverse the trend.
      👍️0
      slugo1 slugo1 3 years ago
      Soon
      👍️0
      ttottip ttottip 3 years ago
      Soon the 2.5's , 2.6's .....
      👍️0
      slugo1 slugo1 3 years ago
      Yes
      👍️0
      ttottip ttottip 3 years ago
      The 2.6's on the horizon.
      👍️0
      slugo1 slugo1 3 years ago
      That's one of the things I like about them Also there should be some updates coming
      👍️0
      ttottip ttottip 3 years ago
      140 millions of dollars cash? ATOS can do great things with this money.
      👍️0
      slugo1 slugo1 3 years ago
      Nice buy worth alot when this hits $10.00
      👍️0
      ttottip ttottip 3 years ago
      Almost 36,000 shares buy at 2.49.
      👍️0
      DrHarleyboy DrHarleyboy 3 years ago
      Good Old "Blue Sky Breakout"././//./..//.///.././..////
      👍️0

      Your Recent History

      NASDAQ
      ATOS
      Atossa Therapeutics
      LSE
      0MD5
      Exel Composites Oyj
      EU
      FR0013249489
      Fcc Elide Bond Matures 2...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads